StockData
Belite Bio, Inc logo

Belite Bio, Inc (BLTE) stock

BLTENasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 31, 2026Score 5/30
$156.23−1.49 (-0.94%)

Close on Nov 18, 2026Market cap $6.15BP/E –Yield –

Belite Bio shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

For fiscal 2025 it was 34M, up 9.8% from the year before. The highest annual figure on record is 34M in fiscal 2025.

Annual shares outstanding

PeriodPeriod endValueChange
FY2025Dec 31, 202534M+9.8%
FY2024Dec 31, 202431M+14.8%
FY2023Dec 31, 202327M+33.1%
FY2022Dec 31, 202220M+108.7%
FY2021Dec 31, 202110M+8.9%
FY2020Dec 31, 20209M–

More Belite Bio figures

See a number that looks wrong?